Tag: targeted
Bristol Myers Squibb’s targeted AML drug Idhifa fails to extend patients’...
Back in 2017, the FDA cleared Celgene's acute myeloid leukemia therapy Idhifa based on complete remission data. But fast forward to today, and the drug has...